LIANY Shariah Compliance
Screening Methodology: AAOIFI
NOT HALAL
Last Updated: January 18, 2025
Report Source: 2023 Annual Report
LianBio. Stock Analysis LIANY
LianBio operates as a biopharmaceutical company, which engages in the development and commercialization of medicines for patients with unmet medical needs. The company is headquartered in Princeton, New Jersey and currently employs 163 full-time employees. The company went IPO on 2021-10-28. The firm is also pursuing the sale of its remaining pipeline assets.
Read More LianBio (LIANY) Chart
Key Statistics of LianBio (LIANY)
Key statistics in the stock market are essential financial indicators that measure a company's performance, valuation, profitability, and risk.
Today's Range
Today's Open
$0.12Volume
40.16KP/E Ratio (TTM)
-52 Week Range
Market Cap
13.26MAvg. Volume
8222.18Dividend Yield
-Financial Metrics & Statements of LianBio (LIANY)
FAQ's for LianBio (LIANY)
- According to Musaffa’s Shariah screening methodology, LianBio (LIANY) is currently classified as NOT HALAL as of January 2025. The classification is based on an evaluation of the company’s business activities and financial ratios to determine whether it meets Islamic investment guidelines.